Clinical Trial Update: Three Way Crossover Closed Loop Study With Xeris Glucagon [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update describing a three-way crossover closed-loop study involving Xeris Glucagon for type 1 diabetes; study completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Xeris Glucagon (glucagon)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Type1diabetes | Phase 1 | Status: COMPLETED | Results posted: 2020-05-13